Medical Xpress February 19, 2025
Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new study finds.
These adverse events included hospitalization, disability, and in a few cases, death. Researchers found that mature generic drugs, those that had been on the market for a relatively long time, were responsible for the finding.
The results show that all generic drugs are not equal, even though patients are often told that they are, said John Gray, co-author of the study and professor of operations at The Ohio State University’s Fisher College of Business.
“Drug manufacturing regulation, and therefore quality assurance practices, differ between emerging economies like India and advanced...
Today's Sponsors
Today's Sponsor